Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.
about
Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study.Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies.Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine.
P2860
Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Negative clinical results from ...... endent immunological response.
@en
Negative clinical results from ...... endent immunological response.
@nl
type
label
Negative clinical results from ...... endent immunological response.
@en
Negative clinical results from ...... endent immunological response.
@nl
prefLabel
Negative clinical results from ...... endent immunological response.
@en
Negative clinical results from ...... endent immunological response.
@nl
P2093
P2860
P1476
Negative clinical results from ...... pendent immunological response
@en
P2093
Dolores Hernández Fernández de Rojas
Elke Decot
Fernando Rodriguez
Klaus Bitsch-Jensen
Mikkel Walmar
Oliver Pfaar
P2860
P304
P356
10.1007/S40261-014-0216-Z
P577
2014-08-01T00:00:00Z